Login / Signup

A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial.

Kensuke HoriShin NishioKimio UshijmaYuka KasamatsuAsumi OkumuraKazuhiro TakeharaKimihiko Ito
Published in: Journal of gynecologic oncology (2021)
UMIN Clinical Trials Registry Identifier: UMIN000017138.
Keyphrases
  • phase ii
  • clinical trial
  • endometrial cancer
  • phase iii
  • open label
  • phase ii study
  • double blind
  • placebo controlled
  • minimally invasive
  • study protocol
  • radiation therapy
  • randomized controlled trial
  • chemotherapy induced